|
Session 116
Poster Abstracts
Dyslipidemia and Cardiovascular Risk in Pediatric Populations
Tuesday, 1:30 - 3:30 pm
Poster Hall |
688
 |
Prevalence of Dyslipidemia in HIV-infected Children Received NNRTI-based ART
Thanyawee Puthanakit*1, L Aurpibul2, T Sirisanthana2, and V Sirisanthana1
1Chiang Mai Univ, Thailand and 2Res Inst for Hlth Sci, Chiang Mai Univ, Thailand |
689
|
Changes in Cholesterol and Triglyceride Levels among Pediatric Patients Treated with Atazanavir, with or without Ritonavir Boosting: The 1020A NIH PACTG Protocol
P Samson1, R Rutstein2, T Fenton1, J Kiser3, C Fletcher3, S Schnittman4, L Mofenson5, E Smith5, B Graham6, Grace Aldrovandi*7, and PACTG 1020A Study Team
1Harvard Sch of Publ Hlth, Boston, MA, US; 2Children's Hosp of Philadelphia, PA, US; 3Univ of Colorado Hlth Sci Ctr, Denver, US; 4Bristol-Myers Squibb, Wallingford, CT, US; 5NIH, DHHS, Bethesda, MD, US; 6Frontier Sci & Tech Res Fndn, Amherst, NY, US; and 7Children’s Hosp of Los Angeles, CA, US |
690
|
Longitudinal Evaluation of Hyperlipidemia in HIV-infected Children Starting their First Line HAART Regimen
José Tomás Ramos*1, S Guillén1, M Martínez1, R Resino2, J Bellón2, J Beceiro3, C Calvo4, M De José5, M Gurbindo2, J Martínez6, and Cohorte de Madrid
1Hosp 12 de Octubre, Madrid, Spain; 2Hosp Gen Univ Gregorio Marañón, Madrid, Spain; 3Hosp Alcala de Henares, Spain; 4Hosp de Leganés, Spain; 5Hosp La Paz, Spain; and 6Hosp del Niño Jesús, Spain |
| 691 |
Carotid Intima Media Thickness and Cardiovascular Markers in HIV-infected Children
Grace McComsey*1,3, M O'Riordan1,3, S Hazen2, N Storer1,3, D El-Bejjani3, S Bhatt4, and V Dogra4
1Rainbow Babies and Childrens' Hosp, Cleveland, OH, US; 2Cleveland Clin Fndn, OH, US; 3Case Western Reserve Univ, Cleveland, OH, US; and 4Univ of Rochester Sch of Med and Dentistry, NY, US |
|
